Compounds > alprenolol

alprenolol and sulfinpyrazone

alprenolol has been researched along with sulfinpyrazone in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (42.86)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (42.86)	29.6817
2010's	1 (14.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Schröder, R	1
Kanazawa, T; Matsuoka, H	1
DeMets, DL; Friedman, LM; Furberg, C; May, GS; Passamani, E	1

Reviews

3 review(s) available for alprenolol and sulfinpyrazone

Article	Year
[Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics]. Deutsche medizinische Wochenschrift (1946), 1981, Apr-24, Volume: 106, Issue:17 Topics: Adrenergic beta-Antagonists; Alprenolol; Anti-Arrhythmia Agents; Aspirin; Dipyridamole; Female; Fibrinolytic Agents; Humans; Male; Myocardial Infarction; Phenprocoumon; Platelet Aggregation; Practolol; Propranolol; Recurrence; Sex Factors; Sulfinpyrazone; Time Factors	1981
[Myocardial infarct: secondary prevention with drugs and their effects]. Nihon rinsho. Japanese journal of clinical medicine, 1980, Volume: 38, Issue:10 Topics: Alprenolol; Aspirin; Dipyridamole; Humans; Myocardial Infarction; Prognosis; Sulfinpyrazone	1980
The randomized clinical trial: bias in analysis. Circulation, 1981, Volume: 64, Issue:4 Topics: Acute Disease; Alprenolol; Atenolol; Clinical Trials as Topic; Clofibrate; Double-Blind Method; Humans; Myocardial Infarction; Patient Compliance; Placebos; Propranolol; Random Allocation; Sulfinpyrazone	1981

Trials

1 trial(s) available for alprenolol and sulfinpyrazone

Article	Year
The randomized clinical trial: bias in analysis. Circulation, 1981, Volume: 64, Issue:4 Topics: Acute Disease; Alprenolol; Atenolol; Clinical Trials as Topic; Clofibrate; Double-Blind Method; Humans; Myocardial Infarction; Patient Compliance; Placebos; Propranolol; Random Allocation; Sulfinpyrazone	1981

Other Studies

4 other study(ies) available for alprenolol and sulfinpyrazone

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010